Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.
about
Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteinsImmunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria.Current status of malaria and potential for control.Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine productionGeneralized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections.Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeysSplenic architecture disruption and parasite-induced splenocyte activation and anergy in Plasmodium falciparum-infected Saimiri sciureus monkeys.Antigenic diversity and variation in blood stages of Plasmodium falciparum.Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparumNYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Preferential binding of Plasmodium falciparum SERA and rhoptry proteins to erythrocyte membrane inner leaflet phospholipids.Variation in the gene encoding a major merozoite surface antigen of the human malaria parasite Plasmodium falciparum.Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum.Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stagesRecent advances in recombinant protein-based malaria vaccines.Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Expression of Plasmodium falciparum surface antigens in Escherichia coli.Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoitesMalaria vaccine development.Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum.Defined Plasmodium falciparum antigens in malaria serology.Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.Malarial proteases and host cell egress: an 'emerging' cascade.Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.Studies on glycoproteins in the human malaria parasite Plasmodium falciparum--lectin binding properties and the possible carbohydrate-protein linkage.An update on candidate malaria vaccines.Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal.Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing.Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
P2860
Q33596771-04F58F9E-3804-4801-9975-16F919AE4A7DQ33598899-E3DB9EC3-7360-4B05-981E-D02C3BB511D2Q33605280-CBA91554-6B68-44FC-8BD8-7CD18106666CQ33608668-EC7A86AC-5F8D-45FC-88D0-D3BE050B23C5Q33772752-DC5E9507-9EDE-491E-A42A-47929B65A2A3Q33975652-C83AB16E-C4E0-4AF7-9192-81F369E8CBA3Q34120959-C08728CF-19ED-46A1-8478-FBFD5846BB13Q34298109-DD3A265D-0DD0-4AE8-8487-256B758BF20FQ34520456-42864C11-995A-4CC8-AA1E-CFA7A7110094Q34541366-F23A98D8-0DB2-4275-8C18-795916CC79DFQ34620173-747121A1-7A1C-419D-968D-D3C5867B9F13Q34628596-E7123DE1-353F-4E73-82B5-1AC00001EC51Q35226199-10FAA814-D64B-44F8-8B27-04B90D8D8ED5Q35272200-1A7AC0D2-E980-481E-A236-4CFB1EDFBE4BQ35383761-77ED584E-FACC-4443-92E5-72DF57B01675Q35519418-B4107A20-05CE-4CFE-BD1F-1668B46BA4EAQ35776265-B3124686-7806-4003-81BB-DDA5B4391868Q36097561-8D9DD862-494D-4A6A-A800-2CFD07FE637AQ36349756-B7E2FCA4-7329-41E4-B072-B6EF969BF7DDQ36354328-C43C9069-17D9-4187-85AA-C421469B9593Q36394182-48CE7F4A-A6B7-40CD-9376-21F653D406AEQ36404193-037DFB51-037E-4123-9DEF-1FBE469BE4D1Q36488514-9C6F840C-1533-4FE4-9598-ED7A7C84A14AQ36489015-7FD56024-A8B1-4F2E-ACA5-AFE89741EE65Q36641624-F0F90044-4371-49B4-B4BE-25DCD8939FF3Q36791080-14B18569-2196-4B6A-B57E-DE6604B242A8Q36799265-1DC72DD6-63E6-4BA4-804A-68E2F657BD8FQ36943106-840F1429-0301-4C19-8C82-C7CB83149FC5Q37029523-09B9B3A0-335D-4DED-89A4-EDA93098D0F2Q37406168-5E70FF53-BFA6-4746-852F-F18783D95907Q37483845-51D0CD44-6534-4DD3-A00F-345E1F5E1071Q38349458-5875DC69-689D-4A12-A78D-3CA09DAABCF7Q38635546-043AE275-912F-4A18-B79F-5FD0CBD2BA69Q38674929-DD1A78FE-A229-4EBC-BD88-97210C3AD03FQ38890556-0C2211B8-3E2A-402A-957D-1AD32F07194DQ39086032-B62B4B18-A844-4D42-80B1-E0328E19428DQ39228943-5D4DC233-AEEB-4003-84A6-CAC5BBCA873AQ39387268-6163E25B-B1BB-4A3A-9F38-2E13B8AC1A70Q39672357-EC72C58F-62A9-4D2A-9B6A-73966C4FD59DQ40055186-BA969C1D-A3D5-4ED9-A011-FB5DFCC4C16E
P2860
Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@ast
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@en
type
label
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@ast
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@en
prefLabel
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@ast
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@en
P2093
P2860
P356
P1476
Antimalarial immunity in Saimi ...... nents of asexual blood stages.
@en
P2093
P2860
P304
P356
10.1084/JEM.160.2.441
P407
P577
1984-08-01T00:00:00Z